Articles by Jan
Each one checked by Biohance EditorialPeptide233 papers~84 people studiedBPC-157: what the studies really showAbout 84 people have received BPC-157 in published research. None got it by the routes most users take.
Jan Polansky4 Nov 20267 min readPeptide1,059 papers0 people studiedTB-500 vs BPC-157: two healing peptides comparedTB-500 has no human study of its own and BPC-157 has reached about 84 people, with no completed injury trial for either.Jan Polansky4 Nov 20267 min readPeptide54 papers~320 people studiedIpamorelin: what we know and what we don'tIpamorelin triggers a growth hormone pulse in one IV study, but no one has published data on the subcutaneous use people actually do.Jan Polansky4 Nov 20265 min read
Jan Polansky4 Nov 20267 min readPeptide1,059 papers0 people studiedTB-500 vs BPC-157: two healing peptides comparedTB-500 has no human study of its own and BPC-157 has reached about 84 people, with no completed injury trial for either.
Jan Polansky4 Nov 20267 min readPeptide54 papers~320 people studiedIpamorelin: what we know and what we don'tIpamorelin triggers a growth hormone pulse in one IV study, but no one has published data on the subcutaneous use people actually do.
Jan Polansky4 Nov 20265 min readWant a protocol built for you?Protocols, the full Vault and live calls with Jan, inside the Room.
Join the Room